24/7 Support Number +91-9137-44-1392

Leukemia

Leukemia

Leukemia

Leukemia is a type of cancer that affects the blood and bone marrow, the spongy tissue inside bones where blood cells are produced. It is characterized by the uncontrolled production of abnormal white blood cells, which are responsible for fighting infections in the body.

In a healthy individual, white blood cells are produced in a controlled manner and mature properly. However, in leukemia, there is a disruption in the normal development and maturation of white blood cells. The abnormal cells, known as leukemia cells or leukemic blasts, multiply rapidly and interfere with the production of normal blood cells.

Types of Leukemia

Leukemia can be broadly categorized into four main types based on the speed of disease progression and the specific type of white blood cells affected. These types are –

  1. Acute Lymphoblastic Leukemia (ALL) – Also known as acute lymphocytic leukemia, ALL is a fast-growing type of leukemia that primarily affects lymphoid cells, which are a type of white blood cells involved in the immune response. ALL is more common in children, but it can also occur in adults.
  2. Acute Myeloid Leukemia (AML) – AML is a rapidly progressing type of leukemia that affects myeloid cells, which give rise to different types of blood cells, including red blood cells, white blood cells, and platelets. AML can occur in both children and adults and is more common in older individuals.

Leukemia

3. Chronic Lymphocytic Leukemia (CLL) – CLL is a slow-growing type of leukemia that primarily affects lymphocytes, a type of white blood cell. It is the most common type of leukemia in adults, particularly in older individuals.

4. Chronic Myeloid Leukemia (CML) – CML is a slowly progressing type of leukemia that affects myeloid cells. It is characterized by the presence of an abnormal chromosome called the Philadelphia chromosome. CML usually has three phases – chronic phase, accelerated phase, and blast crisis.

In addition to these main types, there are rarer subtypes and variants of leukemia that may have distinct characteristics and treatment approaches. Some examples include hairy cell leukemia, adult T-cell leukemia/lymphoma (caused by the human T-cell lymphotropic virus), and acute promyelocytic leukemia (a subtype of AML with a specific genetic abnormality).

Leukemia is a complex and diverse disease, and the classification and treatment options may vary based on individual factors and specific genetic or molecular abnormalities associated with the leukemia cells. A proper diagnosis and consultation with a healthcare professional are necessary to determine the specific type and appropriate management of leukemia.

Causes 

The exact causes of leukemia are often unknown, but certain factors have been identified that may increase the risk of developing the disease. Here are some factors that are associated with an increased risk of leukemia –

  1. Genetic and Hereditary Factors – Certain genetic abnormalities and inherited conditions can predispose individuals to develop leukemia. Examples include Down syndrome, Fanconi anemia, Bloom syndrome, Li-Fraumeni syndrome, and certain rare genetic mutations.
  2. Exposure to Ionizing Radiation – High levels of exposure to ionizing radiation, such as those experienced during nuclear accidents or radiation therapy for previous cancers, have been linked to an increased risk of developing leukemia.
  3. Exposure to Chemicals and Carcinogens – Prolonged exposure to certain chemicals and carcinogens in the environment or workplace may increase the risk of developing leukemia. These include benzene (found in gasoline, tobacco smoke, and certain industrial solvents), formaldehyde, certain pesticides, and some chemotherapy drugs used in the treatment of other cancers.
  4. Smoking – Cigarette smoking has been associated with an increased risk of developing acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), particularly in adults.
  5. Certain Viral Infections – Infections with certain viruses have been linked to an increased risk of specific types of leukemia. For example, human T-cell lymphotropic virus type 1 (HTLV-1) is associated with adult T-cell leukemia/lymphoma, while Epstein-Barr virus (EBV) has been linked to an increased risk of developing some subtypes of Hodgkin lymphoma and Burkitt lymphoma, which are closely related to leukemia.
  6. Chemotherapy and Radiation Therapy – While these treatments are used to treat cancer, they can increase the risk of developing secondary leukemia, particularly in individuals who have received high doses of these treatments.

Having one or more of these risk factors does not necessarily mean that a person will develop leukemia. Many people with leukemia have no identifiable risk factors, and some individuals with multiple risk factors may never develop the disease. The development of leukemia is likely to involve a combination of genetic, environmental, and lifestyle factors, but further research is needed to fully understand its causes.

Symptoms

The symptoms of leukemia can vary depending on the type of leukemia, stage of the disease, and individual factors. Some common symptoms associated with leukemia include –

  1. Fatigue – Feeling tired, weak, or lacking energy is a common symptom of leukemia. This fatigue may be persistent and not relieved by rest.
  2. Pale Skin – Leukemia can cause a decrease in red blood cells (anemia), leading to pale or “washed out” skin.
  3. Easy Bruising or Bleeding – Leukemia can affect the production of platelets, which are responsible for blood clotting. As a result, individuals with leukemia may experience easy bruising, frequent nosebleeds, bleeding gums, or prolonged bleeding from minor cuts.
  4. Frequent Infections – Leukemia can suppress the immune system, making individuals more susceptible to infections. They may experience frequent or severe infections, such as respiratory infections, urinary tract infections, or skin infections.
  5. Swollen Lymph Nodes – Leukemia can cause the lymph nodes, located throughout the body, to swell and become tender.
  6. Unexplained Weight Loss – Unintentional weight loss may occur in individuals with leukemia.
  7. Bone or Joint Pain – Leukemia cells can accumulate in the bone marrow and cause bone or joint pain. This pain is often described as aching or deep.
  8. Abdominal Discomfort – In some cases, leukemia cells may accumulate in the liver or spleen, leading to swelling or discomfort in the abdomen.
  9. Frequent Fevers – Recurrent fevers without an obvious cause may be a symptom of leukemia.
  10. Night Sweats – Profuse sweating during the night, unrelated to the surrounding temperature, can occur in individuals with leukemia.

These symptoms can also be caused by conditions other than leukemia. However, if you experience any persistent or concerning symptoms, it is recommended to consult a healthcare professional for an accurate diagnosis and appropriate evaluation.

Diagnosis and Tests

The diagnosis of leukemia involves several steps and medical tests to determine the presence of leukemia, its type, and other important factors. Here are some common diagnostic procedures and tests used in the evaluation of leukemia –

  1. Medical History and Physical Examination -The healthcare provider will ask about your medical history, including any symptoms you may be experiencing, and perform a physical examination to check for signs of leukemia, such as swollen lymph nodes, enlarged spleen, or unusual bruising.
  2. Complete Blood Count (CBC) – A CBC is a blood test that measures the levels of different types of blood cells, including red blood cells, white blood cells, and platelets. Abnormalities in these cell counts can indicate the presence of leukemia.
  3. Blood Smear – A blood smear involves examining a small sample of blood under a microscope. This test can help identify abnormal shapes, sizes, or numbers of blood cells, which may suggest leukemia.
  4. Bone Marrow Aspiration and Biopsy – These procedures involve taking samples of bone marrow from the hipbone or another large bone using a needle. The samples are then examined to determine the presence of leukemia cells, their type, and other important characteristics. This procedure provides valuable information for the diagnosis and classification of leukemia.
  5. Cytogenetic Analysis – Cytogenetic analysis involves studying the chromosomes within the leukemia cells to identify any specific genetic abnormalities or chromosomal rearrangements. These abnormalities can help determine the type of leukemia and guide treatment decisions.
  6. Flow Cytometry – Flow cytometry is a laboratory technique that analyzes the characteristics and markers on the surface of cells. It is often used to identify and classify leukemia cells based on their specific protein markers.
  7. Molecular Testing – Molecular tests, such as polymerase chain reaction (PCR) or fluorescence in situ hybridization (FISH), can be used to detect specific genetic mutations or alterations associated with certain types of leukemia. These tests can help with diagnosis, prognosis, and treatment decisions.
  8. Lumbar Puncture (Spinal Tap) – In some cases, a lumbar puncture may be performed to collect a sample of cerebrospinal fluid from the spinal canal. This test can help determine if leukemia cells have spread to the central nervous system.

Additional tests and imaging studies may be conducted to assess the extent of the disease, such as computed tomography (CT) scans, magnetic resonance imaging (MRI), or positron emission tomography (PET) scans.

The diagnostic process and specific tests may vary depending on the suspected type of leukemia and individual circumstances. A hematologist or oncologist will guide the diagnostic workup based on the patient’s symptoms, physical examination, and test results.

Treatment

The treatment of leukemia depends on several factors, including the type of leukemia, the stage or phase of the disease, the patient’s age and overall health, and specific genetic or molecular abnormalities associated with the leukemia cells. Treatment approaches for leukemia typically involve a combination of the following –

  1. Chemotherapy – Chemotherapy is the primary treatment for most types of leukemia. It involves the use of powerful medications to kill leukemia cells or stop their growth. Chemotherapy can be administered orally, through injections, or intravenously. Different combinations of drugs and treatment schedules may be used based on the specific type and stage of leukemia.
  2. Targeted Therapy – Targeted therapy is a type of treatment that targets specific genes, proteins, or pathways involved in the growth and survival of leukemia cells. These medications are designed to be more selective in their actions and may have fewer side effects compared to traditional chemotherapy. Examples of targeted therapies used in certain types of leukemia include tyrosine kinase inhibitors (such as imatinib, dasatinib, or nilotinib) for chronic myeloid leukemia (CML) and monoclonal antibodies (such as rituximab) for certain types of chronic lymphocytic leukemia (CLL).
  3. Immunotherapy – Immunotherapy helps to boost the body’s immune system to recognize and destroy leukemia cells. This can be achieved through the use of monoclonal antibodies, immune checkpoint inhibitors, or chimeric antigen receptor (CAR) T-cell therapy. CAR T-cell therapy involves modifying a patient’s own immune cells to specifically target and kill leukemia cells.
  4. Stem Cell Transplantation – Stem cell transplantation, also known as a bone marrow transplant or hematopoietic stem cell transplant, may be recommended for certain cases of leukemia. It involves replacing diseased or damaged bone marrow with healthy stem cells, which can develop into normal blood cells. Stem cells can be obtained from a matched donor (allogeneic transplant) or from the patient’s own body (autologous transplant).
  5. Radiation Therapy – Radiation therapy uses high-energy beams to target and kill leukemia cells. It is commonly used in combination with chemotherapy, especially for certain types of leukemia that have spread to the central nervous system or specific areas of the body.
  6. Supportive Care – Managing the side effects and complications of leukemia treatment is crucial. Supportive care may include medications to prevent or manage infections, blood transfusions to replenish blood cell counts, growth factor injections to stimulate the production of blood cells, and supportive measures to address fatigue, pain, and other symptoms.

The treatment plan for leukemia is highly individualized, and the specific approach will be determined by the healthcare team based on the patient’s condition and response to treatment. Regular monitoring, follow-up visits, and possible adjustments to the treatment plan are common throughout the treatment process.

Outlook

The outlook for leukemia varies widely, ranging from highly curable to more challenging. Advances in treatment have significantly improved survival rates for many types of leukemia, particularly in pediatric cases and chronic myeloid leukemia. Prognosis is influenced by factors such as age, genetic abnormalities, response to treatment, and the presence of other health conditions. Ongoing research and advancements in leukemia treatment continue to improve outcomes and offer new therapeutic options.

Individualized care, regular monitoring, and ongoing follow-up are crucial for optimizing outcomes and maintaining a good quality of life for individuals with leukemia. It is necessary for patients to work closely with their healthcare team to develop a personalized treatment plan and stay informed about their specific prognosis.

We're not just a cancer treatment navigator, we're a community for cancer patients and caregivers because Community is Stronger than Cancer.

© 2024 Uhapo Health Services (P) Ltd.

× How may I help you?